Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Bouloux

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|May 10, 2005
Testim 1% testosterone gel for the treatment of male hypogonadismPierre Bouloux
Acute Medicine|June 10, 2011
Emergency management of phaeochromocytomaAndrew Solomon, Pierre Bouloux
British Journal of Hospital Medicine (London, England : 2005)|October 5, 2006
Endocrine therapies for sarcopenia in older menAndrew Solomon, Pierre Bouloux
Neuron|June 14, 2002
Kallmann syndrome: adhesion, afferents, and anosmiaGavin MacColl, Pierre Bouloux, Richard Quinton
Current Opinion in Investigational Drugs (London, England : 2000)|December 3, 2003
Delivery of testosterone replacement therapyAsjad Hameed, Theresa Brothwood, Pierre Bouloux
Fertility and Sterility|February 1, 2002
Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadismPierre Bouloux, David W Warne, Ernest Loumaye, et al.
Appetite|March 23, 2011
The impact of eating behavior on psychological symptoms typical of reactive hypoglycemia. A pilot study comparing women with polycystic ovary syndrome to controlsJohn A Barry, Pierre Bouloux, Paul J Hardiman
Lancet (London, England)|May 22, 2012
A heart without hormonesJem D Lane, Niall G Keenan, Pierre Bouloux, et al.
European Journal of Endocrinology|August 9, 2021
MANAGEMENT OF ENDOCRINE DISEASE: Dysnatraemia in COVID-19: prevalence, prognostic impact, pathophysiology, and managementPloutarchos Tzoulis, Ashley B Grossman, Stephanie E Baldeweg, et al.
Journal of Hepatology|July 17, 2007
Adrenal insufficiency in liver disease - what is the evidence?James O'Beirne, Michael Holmes, Banwari Agarwal, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|May 10, 2005
Testim 1% testosterone gel for the treatment of male hypogonadismPierre Bouloux
Acute Medicine|June 10, 2011
Emergency management of phaeochromocytomaAndrew Solomon, Pierre Bouloux
British Journal of Hospital Medicine (London, England : 2005)|October 5, 2006
Endocrine therapies for sarcopenia in older menAndrew Solomon, Pierre Bouloux
Neuron|June 14, 2002
Kallmann syndrome: adhesion, afferents, and anosmiaGavin MacColl, Pierre Bouloux, Richard Quinton
Current Opinion in Investigational Drugs (London, England : 2000)|December 3, 2003
Delivery of testosterone replacement therapyAsjad Hameed, Theresa Brothwood, Pierre Bouloux
Fertility and Sterility|February 1, 2002
Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadismPierre Bouloux, David W Warne, Ernest Loumaye, et al.
Appetite|March 23, 2011
The impact of eating behavior on psychological symptoms typical of reactive hypoglycemia. A pilot study comparing women with polycystic ovary syndrome to controlsJohn A Barry, Pierre Bouloux, Paul J Hardiman
Lancet (London, England)|May 22, 2012
A heart without hormonesJem D Lane, Niall G Keenan, Pierre Bouloux, et al.
European Journal of Endocrinology|August 9, 2021
MANAGEMENT OF ENDOCRINE DISEASE: Dysnatraemia in COVID-19: prevalence, prognostic impact, pathophysiology, and managementPloutarchos Tzoulis, Ashley B Grossman, Stephanie E Baldeweg, et al.
Journal of Hepatology|July 17, 2007
Adrenal insufficiency in liver disease - what is the evidence?James O'Beirne, Michael Holmes, Banwari Agarwal, et al.
Pageof 3